SV2A and Alzheimer disease: Quite a few studies have shown that SV2A is involved in several neurological conditions, especially as a biomarker evaluated for synaptic loss in the brain of AD by PET Image (Bastin et al. 2020; Chen et al. 2018; Mecca et al. 2022; Venkataraman et al. 2022).